
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Male Menopause Treatment Market Snapshot
Chapter 4. Global Male Menopause Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ Mn), 2026–2035
4.8. Global Male Menopause Treatment Market Penetration & Growth Prospect Mapping (US$ Mn), 2025–2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/Impact of AI on Male Menopause Treatment Industry Trends
Chapter 5. Male Menopause Treatment Market Segmentation 1: By Alternative Medicine, Estimates & Trend Analysis
5.1. Market Share by Alternative Medicine, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Alternative Medicine:
5.2.1. Acupuncture
5.2.2. Herbal Supplements
5.2.3. Homeopathy
Chapter 6. Male Menopause Treatment Market Segmentation 2: By Hormonal Therapy, Estimates & Trend Analysis
6.1. Market Share by Hormonal Therapy, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Hormonal Therapy:
6.2.1. Estrogen Therapy
6.2.2. Testosterone Replacement Therapy (TRT)
6.2.3. Combination Treatments
Chapter 7. Male Menopause Treatment Market Segmentation 3: By Psychological Counseling, Estimates & Trend Analysis
7.1. Market Share by Psychological Counseling, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Psychological Counseling:
7.2.1. Stress Reduction Programs
7.2.2. Cognitive Behavioral Therapy (CBT)
7.2.3. Support Groups
Chapter 8. Male Menopause Treatment Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Male Menopause Treatment Market Regional Snapshot, 2025 & 2035
8.2. North America
8.2.1. North America Male Menopause Treatment Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.2.1.1. United States
8.2.1.2. Canada
8.2.2. North America Market Revenue Estimates by Alternative Medicine, 2022–2035
8.2.3. North America Market Revenue Estimates by Hormonal Therapy, 2022–2035
8.2.4. North America Market Revenue Estimates by Psychological Counseling, 2022–2035
8.2.5. North America Market Analysis
8.3. Europe
8.3.1. Europe Male Menopause Treatment Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.3.1.1. Germany
8.3.1.2. United Kingdom
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Market Revenue Estimates by Alternative Medicine, 2022–2035
8.3.3. Europe Market Revenue Estimates by Hormonal Therapy, 2022–2035
8.3.4. Europe Market Revenue Estimates by Psychological Counseling, 2022–2035
8.3.5. Europe Market Analysis
8.4. Asia Pacific
8.4.1. Asia Pacific Male Menopause Treatment Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.4.1.1. China
8.4.1.2. Japan
8.4.1.3. India
8.4.1.4. South Korea
8.4.1.5. South East Asia
8.4.1.6. Rest of Asia Pacific
8.4.2. Asia Pacific Market Revenue Estimates by Alternative Medicine, 2022–2035
8.4.3. Asia Pacific Market Revenue Estimates by Hormonal Therapy, 2022–2035
8.4.4. Asia Pacific Market Revenue Estimates by Psychological Counseling, 2022–2035
8.4.5. Asia Pacific Market Analysis
8.5. Latin America
8.5.1. Latin America Male Menopause Treatment Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.5.1.1. Brazil
8.5.1.2. Argentina
8.5.1.3. Mexico
8.5.1.4. Rest of Latin America
8.5.2. Latin America Market Revenue Estimates by Hormonal Therapy, 2022–2035
8.5.3. Latin America Market Revenue Estimates by Psychological Counseling, 2022–2035
8.5.4. Latin America Market Analysis
8.6. Middle East & Africa
8.6.1. Middle East & Africa Male Menopause Treatment Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
8.6.1.1. GCC Countries
8.6.1.2. South Africa
8.6.1.3. Rest of Middle East & Africa
8.6.2. Middle East & Africa Market Revenue Estimates by Hormonal Therapy, 2022–2035
8.6.3. Middle East & Africa Market Revenue Estimates by Psychological Counseling, 2022–2035
8.6.4. Middle East & Africa Market Analysis
Chapter 9. Competitive Landscape
9.1. Major Mergers, Acquisitions & Strategic Alliances
9.2. Company Profiles
9.2.1. Eli Lilly and Company
9.2.2. Pfizer Inc.
9.2.3. AbbVie
9.2.4. Novartis AG
9.2.5. Merck & Co.
9.2.6. Bayer AG
9.2.7. Teva Pharmaceutical Industries
9.2.8. Mylan N.V.
9.2.9. Lupin Ltd.
9.2.10. Ipsen S.A.
9.2.11. GlaxoSmithKline plc
9.2.12. Organon & Co.
9.2.13. Besins Healthcare
9.2.14. Zydus Lifesciences
9.2.15. Cipla Limited
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.